Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: A prospective multicentre study

Annals of Clinical Microbiology and Antimicrobials

Volumn 9, Issue , 2010, Pages

  Ben Mansour, Khansa ^a   Burucoa, Christophe ^b   Zribi, Meriem ^a   Masmoudi, Afef ^a   Karoui, Sami ^a   Kallel, Lamia ^a   Chouaib, Soufiène ^a   Matri, Samira ^a   Fekih, Monia ^a   Zarrouk, Sonia ^c   Labbene, Mounir ^c   Boubaker, Jalel ^a   Cheikh, Imed ^a   Hriz, Mongi B ^d   Siala, Nadia ^d   Ayadi, Abdelkarim ^e   Filali, Azza ^a   Mami, Nabil B ^a   Najjar, Taoufik ^f   Maherzi, Ahmed ^d   Sfar, Mohamed T ^e   Fendri, Chedlia ^a   more..

^a LA RABTA HOSPITAL   (Tunisia)

^b EA 4331 Laboratoire Inflammation Tissus Epithéliaux Cytokines   (France)

^c Hopital de Menzel Bourguiba   (Tunisia)

^d MONGI SLIM HOSPITAL   (Tunisia)

^e Pediatric unit   (Tunisia)

^f CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPSILOMETER TEST; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; GENE MUTATION; GENOTYPE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; REVIEW; SCHOOL CHILD; SEX DIFFERENCE; TUNISIA; ARTICLE; DRUG EFFECT; GENETICS; HELICOBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; POINT MUTATION; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PEPTIC ULCER; POINT MUTATION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TUNISIA; YOUNG ADULT;

EID: 77955479447     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-9-22     Document Type: Review

References (45)

1. Solerman A, Perren A, Schmid S, Eigenmann F, Guller R, Weher KB, Meier F, Eichenberger P, Komminoth P. Assesment of Helicobacter pylori clarithromycin resistance mutations in archival gastric biopsy samples. Swiss Med Wkly 2005, 135:327-332.
2. Djmel N, Khamassi S, Bouzaïdi S, Labbene M, Ben Ammar A, Fendri C, Arrouji Z, Ben Jilani S, Zermani R. Prevalence of Helicobacter pylori in Tunisia: in asymptomatic controls and in none ulcerous dyspepsia and in duodenal ulcer: a prospective study of 183 cases. Tunis Med 1995, 73:373-377.
3. Consensus Actualisation du consensus du traitement de la maladie ulcéreuse gastro-duodénale non compliquée de l'adulte en Tunisie. Journal Officiel de la République Tunisienne Ministère de la santé publique 2006, Avril-Mai, Consensus.
4. Murakami K, Sato R, Okimoto T, Nasu M, Fujioka T, Kodama M, Kagawa J, Sato S, Abe H, Arita T. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Aliment Pharmacol Ther 2002, 16:1933-8. 10.1046/j.1365-2036.2002.01368.x, 12390102.
5. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF. Mutations in 23 S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996, 40:477-480. 163139, 8834903.
6. Gibson JR, Saunders NA, Burke B, Owen RJ. Novel method for rapid determination of calrithromycin sensitivity in Helicobacter pylori. J Clin Microbiol 1999, 37:3746-3748. 85748, 10523591.
7. Marais A, Monteiro L, Occhialini A, Pina M, Lamouliatte H, Mégraud F. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 1999, 44:463-467. 10.1136/gut.44.4.463, 1727470, 10075951.
8. Occhialini A, Urdaci M, Doucet-Populaire F, Bébéar CM, Lamouliatte H, Mégraud F. Macrolides resistance in Helicobacter pylori rapid detection of point mutations and assays of macrolides binding to ribosomes. Antimicrob Agents Chemother 1997, 41:2724-2728. 164196, 9420046.
9. Pina M, Occhialini A, Monteiro L, Doermann HP, Mégraud F. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J Clin Microbiol 1998, 36:3285-3290. 105316, 9774580.
10. Goodwin A, Kersulyte D, Sisson G, Veldhuyzen van Zanten SJ, Berg DE, Hoffman PS. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol 1998, 28:383-393. 10.1046/j.1365-2958.1998.00806.x, 9622362.
11. Lerang F, Moum B, Haug JB, Tolås P, Breder O, Aubert E, Høie O, Søberg T, Flaaten B, Farup P, Berge T. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?. Am J Gastroenterol 1997, 92:248-53.
12. Osato MS, Reddy R, Graham DY. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int J Antimicrob Agents 1999, 12:341-7. 10.1016/S0924-8579(99)00079-5, 10493611.
13. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001, 20:820-3. 10.1007/s100960100611, 11783701.
14. Burucoa C, Garnier M, Silvain C, Fauchère JL. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J Clin Microbiol 2008, 46:2320-2326. 10.1128/JCM.02352-07, 2446943, 18463216.
15. Ben Mansour K, Fendri C, Zribi M, Masmoudi A, Labbene M, Fillali A, Ben Mami N, Najjar T, Meherzi A, Sfar T, Burucoa C. Prevalence of Helicobacter pylori vacA, cagA, iceA and oipA genotypes in Tunisian patients. Annals of Clinical Microbiology and Antimicrobials 2010, 9(10):1-7. 2817643, 20067633.
16. Chaabouni H, Bouzid H, Masmoudi A, Cheikh I, Fendri C, Ben Ammar A. Evaluation in vitro de la résistance primaire de Helicobacter pylori aux antibiotiques chez les maladies souffrant d'ulcère duodénal en Tunisie. Gastroenterol Clin Biol 2004, 28:A135.
17. Norazah A, Zakaria WR, Abdullah SA, Mohamed R. Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. World J Gastroenterol 2009, 15:3161-3165. 10.3748/wjg.15.3161, 2705740, 19575497.
18. Wolle K, Leodolter A, Malfertheiner P, König W. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 2002, 51:705-709.
19. Fellone CA. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can J Gastroenterol 2000, 14:879-882.
20. Ling TKW, Leung WK, Lee CC, Ng EK, Yung MY, Chung MY, Chung SS, Sung JJ, Cheng AF. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001). Helicobacter 2002, 7:327-329. 10.1046/j.1523-5378.2002.00101_1.x, 12390214.
21. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS, Graham DY, Kwon DH. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates form Korea. J Antimicrob Chemother 2001, 47:459-461. 10.1093/jac/47.4.459, 11266421.
22. Laine L, Fennerty MB, Osato M, Sugg J, Suchower L, Probst P, Levine JG. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 2000, 95:3393-3398. 10.1111/j.1572-0241.2000.03349.x, 11151867.
23. Mégraud F. H.pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004, 53:1374-1384. 10.1136/gut.2003.022111, 1774187, 15306603.
24. Mohammedi M, Doroud D, Massarrat S, Farahvach MJ. Clarithromycin resistance in Iranian Helicobacter pylori strains before introduction of clarithromycin. Helicobater 2003, 8:79-80.
25. Baglan PH, Bozdayi G, Ozkan M, Ahmed K, Bozdayi AM, Ozden A. Clarithromycin resistance prevalence and iceA gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J Microbiol 2006, 44:409-416.
26. van Doorn LJ, Glupczynski Y, Kusters JG, Megraud R, Midolo P, Maggi-Soloca N, Quiroz DMM, Nouhan N, Stet E, Quint WGV. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23 S rRNA gene: multicenter validation study. Antimicrob Agent Chemother 2001, 45:1500-1504.
27. Broutet N, Tchamgoué S, Pereira E, Lamouliatte H, Salamon R, Mégraud F. Risk factors for failure of Helicobacter pylori therapy-results of individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003, 17:99-109. 10.1046/j.1365-2036.2003.01396.x, 12492738.
28. Boyanova L. Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J Med Microbiol 2009, 58:930-935. 10.1099/jmm.0.009993-0, 19502370.
29. Alvarez A, Moncayo JI, Santacruz JJ, Santacoloma M, Corredor LF, Reinosa E. Antimicrobial Susceptibility and Mutations Involved in Clarithromycin Resistance in Helicobacter pylori Isolates from Patients in the Western Central Region of Columbia. Antimicrob Agent Chemother 2009, 53:4022-4024.
30. Torres J, Camorlinga-Ponce M, Perez-Perez G, Madrazo-De La G, Dehesa M, Conza'lez-Valencia G, Munoz O. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol 2001, 39:2677-2680. 10.1128/JCM.39.7.2677-2680.2001, 88210, 11427594.
31. Wheeldon TU, Granstrom M, Hoang TT, Phuncarg DC, Nilsson LE, Sorberg M. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication. Aliment Pharmacol Ther 2004, 19(12):1315-1321. 10.1111/j.1365-2036.2004.01959.x, 15191514.
32. Bhatia V, Ahuja V, Das B, Bal C, Sharma MP. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity. J Gastroenterol Hepathol 2004, 19(6):619-625.
33. Glupczynski Y. European Multicentre Study Group on Antibiotic Susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992, 11:777-781. 10.1007/BF01960875, 1468415.
34. Batnavala N, Bavies GR, Abdi Y, Clements L, Rampton DS, Hardie JM. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodénale disease. Gut 1994, 35:1562-1566. 10.1136/gut.35.11.1562, 1375612, 7828973.
35. Koletzko S, Richy F, Bontems P, Crone J, Kalach N, Monteiro ML, Gottrand F, Celinska-Cedro D, Roma-Giannikou E, Orderda G, Kolacek S, Urruzuno P, Martinez-Gomez MJ, Casswall T, Ashorn M, Bodanszky H, Mégraud F. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006, 55:1711-1716. 10.1136/gut.2006.091272, 1856474, 16603633.
36. Kalach N, Benhamou PH, Campeotto F, Bergeret M, Dupont C, Raymond J. Clarithromycin Resistance and Eradication of Helicobacter pylori in Children. Antimicrob Agent Chemother 2001, 45:2134-2135.
37. Lopez-Brea M, Martinez MJ, Domingo D, Alarcon T. A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. J Antimicrob Chemother 2001, 48:295-297. 10.1093/jac/48.2.295, 11481305.
38. Alarcon T, Vega AE, Domingo D, Martinez MJ, Lopez-Brea M. Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-Restriction Fragment Length Polymorphism analysis. J Clin Microbiol 2003, 41:486-488. 10.1128/JCM.41.1.486-488.2003, 149579, 12517902.
39. Mrad S, Boukthir S, Fdhila F, Fendri C, Barsaoui S. Children helicobacter pylori infection: antibiogram results. Tunis Med 2005, 83:599-602.
40. Domingo D, Alarcon T, Sanz JC, Sanchez I, Lopez-Brea M. High frequency of mutations at position 2144 of 23 S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain. J Antimicrob Chemother 1998, 41:573-574. 10.1093/jac/41.5.573, 9630414.
41. De F, Zullo A, Ierardi E, Giorgio F, Perna F, Hassan C, Morini S, Panella C, Vaira D. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrobiol Chemother 2010, 65:327-332.
42. Cederbrant G, Kahlmeter G, Ljungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 1992, 29:115-120. 10.1093/jac/29.2.115, 1506325.
43. Malfertheiner P, Mégraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007, 1954853, 17170018.
44. Zouiten F, Ben Rachid A, Neifer N. About antibiotic consumption in Tunisia. Tunis Med 1999, 77:467-471.
45. Delchier JC. Quelles recommandations pour le management de l'infection à Helicobacter pylori après la troisième conférence de consensus européenne (Maastricht III) ?. Gastroenterol Clin Biol 2006, 30:1361-1364. 10.1016/S0399-8320(06)73555-2, 17211333.